
Results
2
Companies which are more than 50% undervalued based on analyst price target.
2 companies
Pharming Group
Market Cap: €692.8m
A biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally.
PHARM
€0.98
7D
8.2%
1Y
3.9%
Vivoryon Therapeutics
Market Cap: €36.4m
Operates as a clinical stage biopharmaceutical company that focuses on research, development, and commercialize small molecule-based medicines.
VVY
€1.23
7D
2.9%
1Y
-14.8%